p38α mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload

Molecular and Cellular Biology

Volumn 24, Issue 24, 2004, Pages 10611-10620

  Nishida, Kazuhiko ^a,c   Yamaguchi, Osamu ^a   Hirotani, Shinichi ^a   Hikoso, Shungo ^a   Higuchi, Yoshiharu ^a   Watanabe, Tetsuya ^a   Takeda, Toshihiro ^a   Osuka, Soh ^d   Morita, Takashi ^a   Kondoh, Gen ^a   Uno, Yoshihiro ^a   Kashiwase, Kazunori ^a   Taniike, Masayuki ^a   Nakai, Atsuko ^a   Matsumura, Yasushi ^a   Miyazaki, Jun Ichi ^b   Sudo, Tatsuhiko ^d   Hongo, Kenichi ^e   Kusakari, Yoichiro ^e   Kurihara, Satoshi ^e   Chien, Kenneth R ^f   Takeda, Junji ^a   Hori, Masatsugu ^a   Otsu, Kinya ^a,c   more..

^a Dept of Int Med and Therapeutics ^*  (Japan)

^b Div of Stem Cell Reg Research   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^e JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN ALPHA; UNCLASSIFIED DRUG;

ADAPTATION; ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOMECHANICAL STRESS; CELL SURVIVAL; CROSS BREEDING; GENE CONTROL; HEART DILATATION; HEART DISEASE; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE OVERLOAD; KNOCKOUT MOUSE; MALE; MECHANICAL STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; ANIMAL; BLOOD PRESSURE; DOWN REGULATION; FIBROSIS; HEART LEFT VENTRICLE HYPERTROPHY; METABOLISM; MOUSE MUTANT; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BLOOD PRESSURE; CELL SURVIVAL; DOWN-REGULATION; FIBROSIS; HYPERTROPHY, LEFT VENTRICULAR; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 14; MYOCYTES, CARDIAC;

EID: 10044261073     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.24.10611-10620.2004     Document Type: Article

References (38)

1. Adams, R. H., A. Porras, G. Alonso, M. Jones, K. Vintersten, S. Paneill, A. Valladares, I. Perez, R. Kein, and A. R. Nebreda. 2000. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 6:109-116.
2. Agah, R., P. A. Frenkel, B. A. French, L. H. Michael, P. A. Overbeek, and M. D. Schneider. 1997. Gene recombination in postmitotic cells: targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Investig. 100:169-179.
3. Braz, J. C., O. F. Bueno, Q. Liang, B. J. Wilkins, Y. S. Dai, S. Parsons, J. Braunwart, B. J. Glascock, R. Klevitsky, T. F. Kimball, T. E. Hewett, and J. D. Molkentin. 2003. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J. Clin. Investig. 111:1475-1486.
4. Chen, J., S. Kubalak, and K. Chien. 1998. Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development 125:1943-1949.
5. Chevalier, D., and B. G. Allen. 2000. Two distinct forms of MAPKAP kinase-2 in adult cardiac ventricular myocytes. Biochemistry 39:6145-6156.
6. Choukroun, G., R. Hajjar, J. M. Kyriakis, J. V. Bonventre, A. Rosenzweig, and T. Force. 1998. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. J. Clin. Investig. 102:1311-1320.
7. Clerk, A., A. Michael, and P. H. Sugden. 1998. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J. Cell Biol. 142:523-535.
8. Communal, C., W. S. Colucci, and K. Singh. 2000. p38 Mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta-adrenergic receptor-stimulated apoptosis: evidence for Gi-dependent activation. J. Biol. Chem. 275:19395-19400.
9. Date, M., T. Morita, N. Yamashita, K. Nishida, O. Yamaguchi, Y. Higuchi, S. Hirotani, Y. Matsumura, M. Hori, M. Tada, and K. Otsu. 2002. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J. Am. Coll. Cardiol. 39:907-912.
10. Hirota, H., J. Chen, U. A. Betz, K. Rajewsky, Y. Gu, J. Ross, Jr., W. Muller, and K. R. Chien. 1999. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97:189-198.
11. Hoover, H. E., D. J. Thuerauf, J. J. Martindale, and C. C. Glembotski. 2000. Alpha B-crystallin gene induction and phosphorylation by MKK6-activated p38: a potential role for alpha B-crystallin as a target of the p38 branch of the cardiac stress response. J. Biol. Chem. 275:23825-23833.
12. Ivanov, V. N., and Z. Ronai. 2000. p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-kappaB activity and Fas expression. Oncogene 19:3003-3012.
13. Johnson, G. L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912.
14. Kaiser, R. A., O. F. Bueno, D. J. Lips, P. A. Doevendans, F. Jones, T. F. Kimball, and J. D. Molkentin. 2004. Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J. Biol. Chem. 279:15524-15530.
15. Kang, P. M., A. Haunstetter, H. Aoki, A. Usheva, and S. Izumo. 2000. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ. Res. 87:118-125.
16. Kumar, S., P. C. McDonnell, R. J. Gum, A. T. Hand, J. C. Lee, and P. R. Young. 1997. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun. 235:533-538.
17. Lakso, M., J. G. Pichel, J. R. Gorman, B. Sauer, Y. Okamoto, E. Lee, F. W. Alt, and H. Westphal. 1996. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93:5860-5865.
18. Lee, J., J. Laydon, P. McDonnell, T. Gallagher, S. Kumar, D. Green, D. McNulty, M. Blumenthal, J. Heys, S. Landvatter, J. Strickler, M. McLaughlin, I. Siemens, S. Fisher, G. Livi, J. White, J. Adams, and P. Young. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
19. Liao, P., D. Georgakopoulos, A. Kovacs, M. Zheng, D. Lerner, H. Pu, J. Saffitz, K. Chien, R.-P. Xiao, D. A. Kass, and Y. Wang. 2001. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc. Natl. Acad. Sci. USA 98:12283-12288.
20. Ma, X. L., S. Kumar, F. Gao, C. S. Louden, B. L. Lopez, T. A. Christopher, C. Wang, J. C. Lee, G. Z. Feuerstein, and T.-L. Yue. 1999. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99:1685-1691.
21. Mackay, K., and D. Mochly-Rosen. 1999. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes ischemia. J. Biol. Chem. 274:6272-6279.
22. 2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy. FASEB J. 17:61-63.
23. Nemoto, S., Z. Sheng, and A. Lin. 1998. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol. Cell. Biol. 18:3518-3526.
24. Nemoto, S., J. Xiang, S. Huang, and A. Lin. 1998. Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase. J. Biol. Chem. 273:16415-16420.
25. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
26. Otsu, K., N. Yamashita, K. Nishida, S. Hirotani, O. Yamaguchi, T. Watanabe, S. Hikoso, Y. Higuchi, Y. Matsumura, M. Maruyama, T. Sudo, H. Osada, and M. Hori. 2003. Disruption of a single copy of the p38alpha MAP kinase gene leads to cardioprotection against ischemia-reperfusion. Biochem. Biophys. Res. Commun. 302:56-60.
27. Rockman, H., R. Ross, A. Harris, K. Knowlton, M. Steinhelper, L. Field, J. Ross, Jr., and K. Chien. 1991. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 88:8277-8281.
28. Rouse, J., P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanillo, T. Hunt, and A. Nebreda. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027-1037.
29. Sakai, K., and J. Miyazaki. 1997. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem. Biophys. Res. Commun. 237:318-324.
30. Tamura, K., T. Sudo, U. Senftleben, A. M. Dadak, R. Johnson, and M. Karin. 2000. Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102:221-231.
31. Tan, Y., J. Rouse, A. Zhang, S. Cariati, P. Cohen, and M. Comb. 1996. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 15:4629-4642.
32. Utani, A., T. Tanaka, C. Nishigori, Y. Miyachi, K. Danno, S. Imamura, M. Hosokawa, T. Takeda, K. Hirayoshi, and K. Nagata. 1990. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen. Lab. Investig. 63:181-188.
33. Wang, Y., S. Huang, V. P. Sah, J. Ross Jr., J. H. Brown, J. Han, and K. R. Chien. 1998. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273:2161-2168.
34. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
35. Yamaguchi, O., Y. Higuchi, S. Hirotani, K. Kashiwase, H. Nakayama, S. Hikoso, T. Takeda, T. Watanabe, M. Asahi, M. Taniike, Y. Matsumura, I. Tsujimoto, K. Hongo, Y. Kusakari, S. Kurihara, K. Nishida, H. Ichijo, M. Hori, and K. Otsu. 2003. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc. Natl. Acad. Sci. USA 100:15883-15888.
36. Yasukawa, H., T. Yajima, H. Duplain, M. Iwatate, M. Kido, M. Hoshijima, M. D. Weitzman, T. Nakamura, S. Woodard, D. Xiong, A. Yoshimura, K. R. Chien, and K. U. Knowlton. 2003. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J. Clin. Investig. 111:469-478.
37. Zechner, D., D. J. Thuerauf, D. S. Hanford, P. M. McDonough, and C. C. Glembotski. 1997. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J. Cell Biol. 139:115-127.
38. Zhang, S., C. Weinheimer, M. Courtois, A. Kovacs, C. E. Zhang, A. M. Cheng, Y. Wang, and A. J. Muslin. 2003. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J. Clin. Investig. III:833-841.